UBE3A and Angelman syndrome: The identification of these Dube3a targets is the first step in identifying new pathways regulated by UBE3A in humans that are responsible for the underlying defects in both Angelman syndrome and duplication 15q autism and may reveal new therapeutic targets for the treatment of these disorders.